Diverse, Inclusive Studies Are Key to Finding Effective Dementia Treatments

Sponsored ContentWith the aging of the U.S. population, the number of people impacted by Alzheimer’s disease and related dementias (ADRD) is expected to increase. Although these last few years have seen exciting developments with the FDA’s approval of a new “disease-modifying” medication for early Alzheimer’s disease, the search for safer and more effective treatments continues, as does the need to ensure new medications are effective in diverse populations. A key piece of this is expanding our understanding of factors that influence an individual’s risk of disease-related memory loss, and differentiating brain changes that occur with aging vs. disease-related memory loss.Multiple different types of studies are important for addressing these research questions. For example, observational studies, which may involve following individuals over time with memory tests, and sometimes non-invasive brain imaging, help improve our understanding of healthy aging and diseases that cause memory loss. They also help understand the ways in which these diseases impact individuals and families. Additionally, intervention studies (aka clinical trials) assess whether new treatments or lifestyle changes help reduce symptoms of memory loss or improve care for patients living with ADRD. Importantly, those with and without memory concerns and their caregivers may be able to participate in...